Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Goodwin Names COO | Contract Pharma
Breaking News, Promotions & Moves

Goodwin Names COO

Lee rejoins bio-CMO

SooYoung Lee, Ph.D. has returned to Goodwin Biotechnology as chief operating officer. Dr. Lee will report to the newly appointed chief executive officer, Karl Pinto, and will oversee all aspects of Goodwin’s contract manufacturing operations. He previously served at Goodwin as senior vice president, operations from 2010 to 2011.

Dr. Lee has had a multi-decade career in the biological industry. He has held several leadership positions at such biopharma companies and CMOs as SAIC – Frederick, Schering-Plough Research Institute, Wyeth – Lederle Vaccines, AppTec, Neose Technologies and Genencor. He also has extensive experience in international biotechnology operations, having established and served as the director of the Biopharmaceutical Manufacturing Technology Center (BMTC) in Singapore. As a senior member, he helped establish the International Vaccine Institute (IVI) in Seoul, Korea.

“SooYoung’s experiences in process development, tech transfer and GMP manufacturing along with strategic planning and execution will help ensure the delivery of the highest quality services and products that are in compliance with cGMP to our clients, ranging from the smallest biotech start-ups to large biopharma companies,” noted Mr. Pinto. “With this significant addition, we are poised to take the company to new heights.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters